On June 22, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against PharmaCielo Ltd. concerning allegations that the company engaged in misleading transactions and loans with its multi-distributor, and concealed numerous businesses inefficiencies, contamination in some facilities, and outright interoperability.
Read MorePomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Funko, Inc., concerning allegations that the company concealed its lower than average sales volume and was likely to incur a writedown of its inventory.
Read MoreAfter an in-depth vetting process that involved discussions with more than three dozen clients, colleagues, and judges, The Legal 500 ranked Pomerantz as one of the top plaintiffs’ securities litigation firms in the United States.
Read MoreIn an exciting victory for aggrieved Acadia investors, on June 1, 2020, Judge Anthony J. Battaglia of the United States District Court in the Southern District of California, issued an order in In Re Acadia Pharmaceuticals Inc. Securities Litigation granting in part and denying in part Defendants’ motion to dismiss…
Read MoreOn June 3, 2020, Pomerantz LLP was appointed Lead Counsel in an action against 2U, Inc., concerning false positive statements the company made that failed to disclose the increasing competition the company faced in online education …
Read MorePomerantz was appointed Lead Counsel in a securities litigation class action lawsuit against Sprint Corporation, concerning allegations that Sprint made deceptive statements to shareholders …
Read MoreOn May 13, 2020, Pomerantz was appointed Lead Counsel in a class action flied against X Financial, concerning allegations of false or misleading statements by X Financial in its SEC registration statement as to the “continued growth” of its investor base, which rendered the statement inaccurate or misleading.
Read MoreOn May 4, 2020, the 11th Circuit reversed, in part, the district court’s decision in dismissing the Complaint in Luzcak v. National Beverage. The Complaint asserts claims under Sections 10(b) and 20(a) of the Exchange Act charging that Defendants engaged in fraud by misrepresenting alleged “proprietary” metrics “that were key performance indicators” and created National Beverage’s growth…
Read MoreChambers and Partners has recognized Pomerantz LLP as one of the top plaintiffs’ securities litigation firms in the nation and in New York in 2020. Praising Pomerantz as “a prominent player on the plaintiffs' side,” Chambers credits the Firm for being a “highly regarded force [… ] known for taking on major corporate issuers.”
Read MoreOn April 22, 2020, Judge William F. Kuntz II in the U.S. District Court in the Eastern District of New York denied Blue Apron’s motion to dismiss our action in its entirety. In Re Blue Apron Holdings, Inc. Securities Litigation, alleges claims against Blue Apron, a subscription-based meal preparation service that went public in 2017.
Read MoreOn April 7, 2020, Pomerantz was appointed lead counsel in an action against Qudian Inc., concerning materially false and misleading statements regarding its response to regulatory developments in China that threatened to negatively impact Qudian’s full year 2019 financial results, when in reality Qudian’s business was unprepared to mitigate the risks associated with these changes.
Read MoreOn April 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Domo, Inc., brought on by concerns that Domo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Read MoreOn April 6, 2020, Pomerantz succeeded in both defeating the Defendants’ motion to dismiss the third amended complaint against Mylan Pharmaceuticals and in getting the class certified by Judge Oetken in the Southern District of New York.
Read MoreOn March 23, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Forescout Technologies, Inc.
Read MoreOn February 12, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Twitter, Inc, regarding its misrepresentation of “fixes” to user choice settings, which adversely affected its ability to deliver monetized advertisements.
Read MoreOn February 11, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Canopy Growth Corporation, alleging that the Company issued false and/or misleading statements …
Read MoreOn February 3, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against PG&E Corporation, alleging that PG&E’s new, “enhanced” wildfire prevention and safety protocols were misrepresented as adequate …
Read MoreOn January 10, 2020, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Zynerba Pharmaceuticals, Inc., regarding allegations that Zynerba failed to disclose details discovered in trials of its transdermal CBD gel product, Zygel.
Read MoreOn January 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Match Group, Inc., regarding allegations that the Company failed to disclose adverse facts about its practice of bating customers of its dating products with fake love interest ads …
Read MoreOn January 2, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Eldorado Resorts, Inc., alleging that several of the Company’s officers knowingly disregarded Eldorado’s Code of Ethics and Business Conduct.
Read More